{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-21-000106","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.839855+00:00","generated_at":"2026-06-28T13:31:21.141402+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"LifeVantage Q1 FY2022 revenue $53.2M (-2.9% YoY); adjusted EPS $0.23 (-8%)","bullets":["Revenue of $53.2M, down 2.9% YoY; Americas -5.8%, Asia/Pacific & Europe +3.9%.","GAAP diluted EPS $0.25 (+47.1%); adjusted diluted EPS $0.23 (-8.0%); adjusted EBITDA $5.8M (-13.7%).","Total active accounts fell 4.7% to 164k; Americas -9.4% partly offset by Asia/Pacific & Europe +8.9%.","Repurchased ~0.5M shares for $3.5M; cash $19.9M, no debt.","FY2022 guidance reaffirmed: rev $225-235M, adj. EBITDA $22-24M, adj. EPS $0.83-0.87."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-21-000106","json":"https://secwatch.observer/filing/0000849146-21-000106.json","markdown":"https://secwatch.observer/filing/0000849146-21-000106.md","text":"https://secwatch.observer/filing/0000849146-21-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914621000106/0000849146-21-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914621000106/lfvn-20211104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:31:21.141402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}